Human Molecular Genetics Advance Access published online on September 22, 2004
Human Molecular Genetics, doi:10.1093/hmg/ddh300
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Hacettepe University Medical Faculty, Department of Pediatrics, Child Neurology, 06100 Ankara, Turkey
* To whom correspondence should be addressed. E-mail: fischer{at}cng.fr.
L-2-hydroxyglutaric aciduria is characterized by progressive deterioration of central nervous system function including epilepsy and macrocephaly in 50% of cases plus elevated levels of L-2-hydroxyglutaric acid in urine, blood, and cerebrospinal fluid (CSF). Nuclear magnetic resonance imaging shows distinct abnormalities. We report the identification of a gene for L-2-hydroxyglutaric aciduria (MIM 236792) using homozygosity mapping. Nine homozygous mutations including three missense mutations, two nonsense mutations, two splice site mutations and two deletions were identified in the gene C14orf160, localized on chromosome 14q22.1, in 21 patients from one non-consanguineous and 14 consanguineous Turkish families. We propose to name the gene duranin. Duranin encodes a putative mitochondrial protein with homology to FAD-dependent oxidoreductases. The functional role of this enzyme in intermediary metabolism in humans remains to be established.
Article
L-2-hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1
2 Centre National de Génotypage, 91057 Evry, France
3 Hacettepe University Medical Faculty, Department of Pediatrics, Metabolism and Nutrition, 06100 Ankara, Turkey
4 Istanbul University Cerrahpasa Medical Faculty, Department of Neurology, 34098 Istanbul, Turkey
5 University Hospital Amsterdam, Department of Pediatrics and Clinical Chemistry, Laboratory for Genetic Metabolic Diseases, 1105 AZ Amsterdam, The Netherlands
6 Généthon, 91000 Evry, France
7 Hacettepe University Medical Faculty, Tübitak DNA and Cell Bank, 06100 Ankara, Turkey
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. E. Steenweg, G. S. Salomons, Z. Yapici, G. Uziel, E. Scalais, D. I. Zafeiriou, M. L. Ruiz-Falco, V. Mejaski-Bosnjak, P. Augoustides-Savvopoulou, M. Wajner, et al. L-2-Hydroxyglutaric Aciduria: Pattern of MR Imaging Abnormalities in 56 Patients Radiology, June 1, 2009; 251(3): 856 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Samuraki, K. Komai, Y. Hasegawa, M. Kimura, S. Yamaguchi, N. Terada, and M. Yamada A SUCCESSFULLY TREATED ADULT PATIENT WITH l-2-HYDROXYGLUTARIC ACIDURIA Neurology, March 25, 2008; 70(13): 1051 - 1052. [Full Text] [PDF] |
||||
![]() |
J. Penderis, J. Calvin, C. Abramson, C. Jakobs, L. Pettitt, M. M Binns, N. M Verhoeven, E. O'Driscoll, S. R Platt, and C. S Mellersh L-2-hydroxyglutaric aciduria: characterisation of the molecular defect in a spontaneous canine model J. Med. Genet., May 1, 2007; 44(5): 334 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lee, M. Born, G. S. Salomons, C. Jakobs, and J. Woelfle Hemiconvulsion-Hemiplegia-Epilepsy Syndrome as a Presenting Feature of L-2-Hydroxyglutaric Aciduria J Child Neurol, June 1, 2006; 21(6): 538 - 540. [Abstract] [PDF] |
||||



